August 2011
Preliminary Injunction Upheld to Enforce Forum Selection Clause Where Continuations of Licensed Patents Are Impliedly Licensed
[Appealed from D.N.M., Judge Browning]
Claim Differentiation Does Not Trump Written Description in Claim Construction
[Appealed from E.D. Tex., Chief Judge Folsom]
Disclosure of a Less-Than-Ideal Use of a Prior Art Compound Is Sufficient to Render It Foreseeable for Purposes of Prosecution History Estoppel
[Appealed from S.D.N.Y., Senior Judge Sand]
Merely Pointing Out Differences in What the Claims Cover Is Not a Substantive Argument as to Separate Patentability of the Claims
[Appealed from Board]
Isolated DNA Is Patent-Eligible Subject Matter Under 35 U.S.C. § 101
[Appealed from S.D.N.Y., Senior Judge Sweet]
Federal Circuit Affirms Exceptional Case Finding and Rule 11 Sanctions Against a Patent-Holding Company and Its Counsel
[Appealed from W.D. Wash., Judge Martinez]
Abbreviations | |
ALJ | Administrative Law Judge |
ANDA | Abbreviated New Drug Application |
APA | Administrative Procedures Act |
APJ | Administrative Patent Judge |
Board | Board of Patent Appeals and Interferences |
Commissioner | Commissioner of Patents and Trademarks |
CIP | Continuation-in-Part |
DJ | Declaratory Judgment |
DOE | Doctrine of Equivalents |
FDA | Food and Drug Administration |
IDS | Information Disclosure Statement |
ITC | International Trade Commission |
JMOL | Judgment as a Matter of Law |
MPEP | Manual of Patent Examining Procedure |
NDA | New Drug Application |
PCT | Patent Cooperation Treaty |
PTO | United States Patent and Trademark Office |
SJ | Summary Judgment |
TTAB | Trademark Trial and Appeal Board |